GB201305103D0 - An oral dosage form - Google Patents
An oral dosage formInfo
- Publication number
- GB201305103D0 GB201305103D0 GB201305103A GB201305103A GB201305103D0 GB 201305103 D0 GB201305103 D0 GB 201305103D0 GB 201305103 A GB201305103 A GB 201305103A GB 201305103 A GB201305103 A GB 201305103A GB 201305103 D0 GB201305103 D0 GB 201305103D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage form
- oral dosage
- oral
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006186 oral dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1305103.2A GB2512098A (en) | 2013-03-20 | 2013-03-20 | An oral dosage form |
| PCT/GB2014/050792 WO2014147377A1 (en) | 2013-03-20 | 2014-03-14 | An oral dosage form having an outer surface comprising a medicated print |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1305103.2A GB2512098A (en) | 2013-03-20 | 2013-03-20 | An oral dosage form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB201305103D0 true GB201305103D0 (en) | 2013-05-01 |
| GB2512098A GB2512098A (en) | 2014-09-24 |
Family
ID=48226736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1305103.2A Withdrawn GB2512098A (en) | 2013-03-20 | 2013-03-20 | An oral dosage form |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB2512098A (en) |
| WO (1) | WO2014147377A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10898447B2 (en) | 2016-10-27 | 2021-01-26 | Psirrros Inc. | Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use |
| RU2674692C2 (en) * | 2016-10-27 | 2018-12-12 | Общество с ограниченной ответственностью "Инжиниринговый сервис и консалтинг" | Ready medical form with possibility of individual dosing of medicine, method of its manufacture and application |
| CN113874000A (en) * | 2019-04-22 | 2021-12-31 | 尼普洛株式会社 | Method for producing pharmaceutical preparation |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2849494A1 (en) * | 1978-11-15 | 1980-05-29 | Voss Gunter M | METHOD FOR THE PRODUCTION OF MEDICINAL FORMS |
| GB2074947B (en) * | 1980-04-23 | 1984-10-10 | Thomae Gmbh Dr K | Printing on pharmaceutical mouldings tablets or coated tablets |
| DE19940241A1 (en) * | 1999-08-25 | 2001-03-01 | Lohmann Therapie Syst Lts | Method for applying at least one active substance to a thin substrate forming a carrier layer involves use of liquid active substances which are applicable by bubble jet printing techniques |
| US20040219109A1 (en) * | 2003-03-10 | 2004-11-04 | Hatch Edwin Burton | Printing identification of incorporated medications onto medicated chewing gums, medicated candies, and other medicated edible products |
| US20040253185A1 (en) * | 2003-06-12 | 2004-12-16 | Atrium Medical Corp. | Medicated ink |
| US8080097B2 (en) * | 2003-11-06 | 2011-12-20 | Hewlett-Packard Development Company, L.P. | System and a method for the creation of edible, optically invisible images |
| JP2008522970A (en) * | 2004-12-06 | 2008-07-03 | レリアント ファーマスーティカルズ インコーポレイテッド | Omega-3 fatty acids and dyslipidemic agents for lipid therapy |
| CA2600429A1 (en) * | 2005-03-08 | 2006-09-14 | Reliant Pharmaceuticals, Inc. | Treatment with statin and omega-3 fatty acids and a combination product thereof |
| WO2006099618A1 (en) * | 2005-03-16 | 2006-09-21 | Dr. Reddy's Laboratories Ltd. | Delivery system for multiple drugs |
| EP2081550B2 (en) * | 2006-03-09 | 2021-05-26 | Reliant Pharmaceuticals, Inc. | Coating capsules with active pharmaceutical ingredients |
| JP2009541433A (en) * | 2006-06-26 | 2009-11-26 | ヴァルファルマ ソチエタ アノニマ | Pharmaceutical compositions for oral administration of omega polyene fatty acids, and one or more incompatible ingredients and the process of their preparation |
| US20080026040A1 (en) * | 2006-07-31 | 2008-01-31 | Isaac Farr | Active agent-releasing dosage forms |
| KR101310710B1 (en) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor |
| IN2014DN03370A (en) * | 2011-10-28 | 2015-06-05 | Hewlett Packard Development Co |
-
2013
- 2013-03-20 GB GB1305103.2A patent/GB2512098A/en not_active Withdrawn
-
2014
- 2014-03-14 WO PCT/GB2014/050792 patent/WO2014147377A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014147377A1 (en) | 2014-09-25 |
| GB2512098A (en) | 2014-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274024A (en) | Oral compositions | |
| IL278183A (en) | Proton-binding polymers for oral administration | |
| IL246377A0 (en) | Oral pharmaceutical composition | |
| GB201306610D0 (en) | Pharmaceutical compounds | |
| IL245124A0 (en) | Abuse-deterrent dosage forms | |
| SG11201510442TA (en) | Oral composition | |
| SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
| IL245705A0 (en) | Pharmaceutical dosage forms | |
| PL3089593T3 (en) | Advanced gum forming | |
| GB201305103D0 (en) | An oral dosage form | |
| DK3052087T3 (en) | Implantable solid dosage form | |
| GB2520315B (en) | Oral Syringes | |
| GB201316431D0 (en) | Dental Phantom | |
| GB201320786D0 (en) | Medicament | |
| HU4880U (en) | Inhalator | |
| GB201316662D0 (en) | Pharmaceutical Combination | |
| GB201321316D0 (en) | Pharmaceutical Compound | |
| GB201315734D0 (en) | Pharmaceutical compounds | |
| GB201309405D0 (en) | Pharmaceutical compound | |
| GB201308780D0 (en) | Pharmaceutical compounds | |
| GB201308781D0 (en) | Pharmaceutical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |